Tenaya Therapeutics (TNYA)

• Market cap: $192M
• 1 day: -1.67%
• 5 days: -13.87%
• 1 month: 1.72%
• 3 months: 89.62%
• 6 months: 61.64%
• Year to date: -16.9%
• 1 year: -40.7%
• 5 years: -92.31%
• 10 years: -92.31%
• Sector: Healthcare
• Industry: Biotechnology

About: Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Employees: 97

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

180% more call options, than puts

Call options by funds: $137K | Put options by funds: $49K

9% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 23

0% more funds holding in top 10

Funds holding in top 10: 3 [Q1] → 3 (+0) [Q2]

11.82% less ownership

Funds ownership: 31.23% [Q1] → 19.41% (-11.82%) [Q2]

16% less funds holding

Funds holding: 105 [Q1] → 88 (-17) [Q2]

30% less capital invested

Capital invested by funds: $27.5M [Q1] → $19.3M (-$8.13M) [Q2]

45% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 38

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $5
• Avg. target: $7
• High target: $9

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Joseph Pantginis	$5	Buy Reiterated	2 Sep 2025
Chardan Capital Geulah Livshits	$9	Buy Maintained	7 Aug 2025